The mutational status of NOTCH1 is the only validated risk factor for transformation, with a significantly higher cumulative probability of patients with CLL developing DLBCL variant (45%) compared to CLL without NOTCH1 mutations (4%) [19–21]. This evidence concerns the gene NOTCH1 and diffuse large B-cell lymphoma.